Feb. 23, 2024: State Advocacy Update
AMA urges continued support for New York’s Committee for Physician Health and more in the latest State Advocacy Update.
Top news stories from AMA Morning Rounds®: Week of Feb. 12, 2024
In the news: Flu activity on the rise after national decline, salt substitutes and BP risk, FTC and HHS investigate generic drug shortages and more.
AMA Advocacy Insights webinar series
AMA Advocacy Insights webinar series examines key advocacy issues from the federal and state levels impacting patients and physicians.
AMA advocacy efforts
The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of some of the recent efforts.
Meet new DEA training requirement
Satisfy the new eight-hour MATE Act training requirement on treating patients with opioid or other substance use disorders with CME from AMA Ed Hub™.
Add flexibility on buprenorphine Rx for opioid-use disorder
Nation’s worsening opioid-overdose epidemic prompts AMA call to eliminate buprenorphine dose limits to provide adequate treatment. Learn more.
Jan. 26, 2024: National Advocacy Update
Bipartisan Substance Use Disorder Workforce Act reintroduced in the House and more in the latest National Advocacy Update.
Why we must act quickly and decisively to end the overdose epidemic
The nation’s drug-related overdose and death epidemic demands immediate and collective action, with physicians taking the lead.
The nation’s overdose epidemic is growing in complexity
Over 107,000 Americans died of a drug-related overdose last year, but payers have yet to step up to boost access to lifesaving treatment.